bit.bio is a series b startup based in United Kingdom. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
bit.bio programs cells for new medicines. The company's opti-ox technology enables precise, consistent and scalable manufacturing of human cells.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky